The Real ME: A Stock Photography Resource for the Media
We’ve all seen them in the news stories about ME/CFS: the guy in a suit at the office, yawning; the beautiful woman sitting at her desk with her immaculate make-up and elegantly coiffed hair, hand to her head and looking slightly pained.
Discuss the article on the Forums.

‘Nanocarriers’ To Treat Cancer, Inflammatory Diseases

Discussion in 'Other Health News and Research' started by Waverunner, Sep 13, 2012.

  1. Waverunner

    Waverunner Senior Member

    Messages:
    1,025
    Likes:
    921
    Could be relevant for the inflammatory parts of CFS.

    http://detroit.cbslocal.com/2012/09...rriers-to-treat-cancer-inflammatory-diseases/

    DETROIT — A Wayne State University research team in the Eugene Applebaum College of Pharmacy and Health Sciences has developed a novel approach to the design of nanocarriers for treatment of metastatic cancer and inflammatory diseases.
    Published in the prestigious international chemistry journal Angewandte Chemie, the study “Dual-function CXCR4 Antagonist Polyplexes to Deliver Gene Therapy and Inhibit Cancer Cell Invasion” introduces a new type of nanocarriers that have unique dual functionality.
    “The nanocarriers not only limit metastasis and inflammation, but also deliver additional therapeutic agents with anticancer or anti-inflammatory activity,” said associate professor David Oupicky, who heads the research team in the college’s department of pharmaceutical sciences.
    In describing the design, Oupicky said, “Published reports suggest that certain drugs, called CXCR4 antagonists, can limit tumor growth and metastasis in various cancers. This makes the CXCR4 receptor a suitable target for the development of combination nanocarriers that control cancer metastasis and can deliver a second knock-out punch.”
    ...
     

See more popular forum discussions.

Share This Page